​

​ In partnership with

​

From 1000+ Papers to a Lit Review in Minutes

Stop wrestling with PubMed and black-box AI. Spine is the first iterative deep research tool that gives you control. Go from a query to a fully-sourced draft, then deepen your review with full transparency. Perfect for lit reviews, grant proposals, and analyzing new FDA rules. See how we did it.

​

🔎 PanDerm: AI Revolutionizes Dermatology with Multimodal Diagnosis

🔬 Breakthrough:​
PanDerm is a foundation vision model that processes multiple dermatology image types—clinical, dermoscopic, pathology, and full-body photos. Tested across 28 diagnostic tasks, it achieved state‑of‑the‑art accuracy using just 10% of labeled data.

💡 Clinical Impact:​
This system could significantly boost diagnostics in skin cancer and general dermatology, enabling non‑specialists to achieve expert-level performance—especially valuable in settings lacking dermatology infrastructure.

📊 Relevant Data & Numbers:

• Trained on >2 million images from 11 institutions
• Improved dermatologist accuracy by ~11% on dermoscopy
• Outperformed clinicians by 10.2% in early melanoma detection

​

🩺 LarkVantage Helps Providers Manage GLP‑1 Costs with AI Support

🔬 Summary:​
Lark has unveiled LarkVantage, an AI tool designed for payers and providers to manage soaring GLP‑1 therapy costs. It analyzes patient data in real time, matching treatments to guidelines to optimize outcomes and reduce unnecessary approvals.

💡 Clinical Impact:​
By guiding evidence‑based formulary decisions, LarkVantage aims to balance clinical effectiveness with cost, easing payer-provider tensions and standardizing GLP‑1 utilization.

• Cost‑pressure tool tuned for expensive newer therapies
• Real‑time guideline alignment for GLP‑1 prescriptions

​

🏥 Abridge Expands AI Note & Orders Tool into Inpatient Care

🔬 Summary:​
Abridge Inside now supports inpatient workflows alongside outpatient orders, enabling automated, billable notes and conversationally surfaced medication orders—all seamlessly integrated into Epic via Haiku and Hyperspace.

💡 Clinical Impact:​
Clinicians can chart and order medications hands-free, streamlining documentation and reducing cognitive overhead across complex care settings.

• Supports H&P, progress, and consult notes
• Order surfacing aligns medications mentioned in conversation

​

🦴 MSKAI’s Spine AI Secures FDA 510(k) for Clinical Deployment

🔬 Summary:​
MSKAI has received FDA 510(k) clearance for its AI-powered spine imaging software—designed to analyze spinal anatomy and pathology, aiding radiologists with segmentation and measurements in routine clinical practice.

💡 Clinical Impact:​
Built for real-world use, this FDA-cleared tool integrates into workflows to improve diagnostic efficiency and consistency for spine MRI and CT interpretation.

• FDA-cleared for segmentation and anatomical assessment
• Enables faster, standardized spine evaluations

​